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Abstract. Extensive survival data are presented from
the EDTA Registry's files for patients who started
renal replacement therapy in 1970-1974 compared to
1980-1984. The contribution of the different treatment
modalities (haemodialysis, continuous peritoneal dialysis,
and transplantation) to the survival of patients according
to geographical region is also shown. Survival on renal
replacement therapy, irrespective of treatment modality
and of primary renal disease, was best in the 10-14-year-
old patients, with 58% at 10 years and 52% at 15 years,
and decreased with rising age to 28% at 10 years and 16%
at 15 years in patients aged 45-54 when they commenced
therapy in 1970-1974. When comparing the 0-4-year-old
with the 10-14-year-old cohort of the paediatric patients,
5-year survival rates for patients starting renal replace-
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ment therapy in the early eighties declined from 85% to
70% with decreasing age.
Treatment policy, as reflected by the proportion of
patients on different modes of therapy, varied markedly
between European regions but affected survival to a small
extent only. The large population with diabetic nephro-
pathy incurred annual mortality rates 2-3 times greater
than those observed in patients with 'standard' primary
renal diseases. Haemodialysis and continuous peritoneal
dialysis, although not comparable because of important
differences in selection policy, yielded similar survival
rates.
Patient and graft survival rates have improved
markedly when comparing patients starting renal replace-
ment therapy in the early seventies with the eighties;
particularly for cadaveric transplantation. Patient sur-
vival after second grafting was similar to that after first
grafting, with 83% at 5 years after second cadaveric
grafting in the 15-44-year-old cohort, vs 85% after first
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cadaver transplantation in 1980-1984. Second cadaveric
graft survival was superior to average first-graft survival
for those recipients whose first graft had been functioning
for more than 1 year. However, second-graft survival in
rapid rejectors of a first graft as well as third cadaveric
graft survival were curtailed by the large number of early
losses, with only 52% of third grafts functioning at 1 year.
For living related donor transplantation, parents were
mostly used in children whilst identical siblings pre-
dominated in adults older than 45. In the early eighties,
patient survival was 92% at 5 years for recipients
younger than 15. 87% for the 15-45 year old cohort
and 72% for those aged 45 or older. From the overall
survival rates on renal replacement therapy obtained at
5 years in the early eighties, it appears safe to predict
that at least 65% of young adults and 25% of patients
aged 55-64 will be surviving at 10 years after starting
therapy.
Key words: EDTA Registry; Diabetic nephropathy; Graft
survival; Patient survival after renal transplantation;
Regraft survival; Survival on CAPD; survival on haemo-
dialysis; Survival on renal replacement therapy
Introduction
The EDTA Registration Committee has been asked by
many members of EDTA-ERA to provide comprehensive
survival data for patients on renal replacement therapy in
Europe. Particular interest is anticipated, on the one hand
for survival achieved in recent years, and on the other
hand for long-term survival beyond 10 years. It seemed
appropriate, therefore, to present survival data for
patients starting treatment during the first 5 years of the
last decade (1970-1974) and compare them to the cohort
starting from 1980 to 1984. Factors that might affect
survival such as age and primary renal disease are also
taken into account. Finally, the contribution of different
methods of treatment to the survival on renal replacement
therapy is examined in relation to age of patients at start
of treatment and its wide variation between geographical
regions.
Methods
The methods of data collection used by the EDTA
Registry have been described previously [1]. This report is
based on data provided on individual patient question-
naires and relates to treatment up to 31 December 1985.
Patient and graft survival estimates were calculated using
the actuarial method, and calculations to define the
proportional contributions of the various treatment
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modalities to renal replacement therapy and patient
survival were carried out by the methodology developed
by Dr. Neville Selwood and previously described [2].
Survival After First Renal Replacement Therapy
Survival on renal replacement therapy has improved
markedly in one decade. This is readily apparent for all
age groups up to 65 shown in Table 1 and to a lesser extent
also for the group aged over 65 at start of treatment.
However, the survival figures given in Table 1 for patients
over 65 may not usefully be compared, as the large differ-
ence in the numbers of patients in this group for the
two periods studied was due to a substantial number of
70-80-year-olds beginning renal replacement therapy in
1980-1984. It is possible that the more liberal intake of
older patients in recent years has also included an increas-
ing number of high-risk candidates. It is no surprise that
survival on renal replacement therapy still does not
approach survival rates of the general population which,
according to official statistics from many European
countries, show an annual mortality of some 0.05% for
children aged 5-14 years, of 0.1 %-0.2% for young adults
aged between 15 and 45 years, of 0.3%-0.8% for the
45-54 age cohort and of 0.7%-1.0% for females and
1.5%-2.0% for males aged 55-64 [3].
Annual mortality on renal replacement therapy
decreased with length of time on therapy, which is demon-
strated in a semilogarithmic plot (Fig. 1) by an upturn in
the survival curves [4]. This was more apparent in the
younger as compared to the older cohorts, and also in
those starting treatment in the early seventies as compared
to those starting in the early eighties. That annual mor-
tality decreased with time on renal replacement therapy is
also shown in Fig. 2 for the three large age cohorts starting
treatment in 1970-1974. Annual mortality decreased
from 13.5% during the first year of therapy to 2%-3% at
10-15 years in the 15-34-year-old cohort, from 16% to
5%-7.5% in those aged 35-44 at start of therapy, and
from 17% to 10%-ll% in the 45-54-year-old group.
Decreasing mortality with time is encouraging, since rising
age is. in general, associated with a steady increase in
mortality.
Most likely explanations for this finding include the
more rapid drop-out of high-risk patients, such as young
patients with diabetes mellitus, higher transplantation
rates in the early years on renal replacement therapy with
increased mortality in the first few months after trans-
plantation, and improving quality of treatment in the
course of the last 10-15 years. Figure 3 suggests that
improving quality of renal replacement therapy is unlikely
to be the sole explanation. This compares the interval
mortality of two age cohorts. Those patients who com-
menced renal replacement therapy in 1980-1984 (shown
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Table 1. Patient survival after first renal replacement therapy, according to age at start of treatment. Results are given according to year of first renal
replacement therapy (RRT). Number of patients at risk at time zero (n) is shown. An asterisk (*) denotes less than 30 patients at risk
Age at
first
RRT
0-4
5-9
10-14
15-34
35-44
45-54
55-64
£65
Year of first renal replacement therapy
1980-1984
n
297
676
1404
18 972
15048
21866
21885
16 562
% Survival
ly r
86
91
96
93
91
90
86
78
2yr
80
87
91
88
84
81
74
61
3yr
75
85
89
85
79
74
65
49
4yr
73
82
87
82
74
67
57
39
5yr
70
82
85
80
70
61
49
31
1970-1974
n
34
182
570
9404
7073
7 160
3 251
584
% Survival
2yr
59
70
80
78
73
71
64
56
4yr
*
55
72
68
59
54
43
33
6yr
•
47
66
62
51
44
30
20
Syr
•
44
61
58
45
35
21
12
10 yr
*
43
58
54
41
28
14
7
12 yr
•
41
57
51
35
23
10
*
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*
*
52
48
28
16
•
•
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Fig. 1. Patient survival after first renal replacement therapy according to
age group and year at start of treatment.
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Fig. 2. Annual mortality after first renal replacement therapy (RRT)
1970-1974. according to age group.
in the left panel) had higher annual mortality rates than
their counterparts of the same age who had spent 10
additional years on treatment (right panel). Although
interval mortality was decreasing less with time in the
cohort commencing treatment in 1980-1984, it would
seem safe to predict that survival at 10 years for patients
who commenced renal replacement therapy in 1980-1984
would be going to exceed 72% (i.e. 85% of 85%, Table 1
and Fig. 1) for the paediatric cohort aged 10-14 years and
25% (i.e. 50% of 50%) for the 55-64-year-old cohort.
Age at start
of RRT .0 Age 10 yearsafter start of
RRT
\ annual
mortality
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Fig. 3. Annual mortality on renal replacement therapy (RRT)
1980-1985. according to age group.
Survival on Renal Replacement Therapy in
Different Regions of Europe
In order to compare geographical differences in the
approach to renal replacement therapy, six groups of
countries were studied. The proportional use of different
methods of therapy were similar within each of the
groups. Comparison between these groups of countries
should highlight different survival trends on the European
scene. Patient survival figures computed for these
geographical regions (Table 2) can be regarded as a
summary of the results of national programmes. (National
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Table 2. Patient survival after first renal replacement therapy (RRT), according to age at start of treatment in six regions of Europe
Age at
first
RRT
(years)
Year of first i
1980-1984
n
renal replacement therapy
% Survival
1 yr 2 yr
Latin (France. Italy. Portugal,
0-14
15-44
45-64
»65
867
10113
15 505
6 798
95
97
92
81
Spain)
91
93
84
64
3yr
89
91
76
52
Benelux (Belgium. Luxembourg, Netherlands)
0-14
15-44
45-64
5=65
149
1395
2 348
I 145
95
95
88
78
British Isles (United Kingdom.
0-14
15 44
45-64
» 65
359
3 649
3 830
609
93
94
84
69
91
92
79
63
Ireland)
91
89
73
53
Federal Republic of Germany. Austria
0-14
15-44
45-64
2s 65
285
5 072
8 886
3 877
Nordic (Denmark. Finland
0-14
15-44
45-64
2*65
93
1609
2 080
849
95
95
88
79
94
89
78
61
89
89
70
so
87
86
65
44
93
85
69
49
. Iceland. Norway. Sweden)
93
88
79
66
90
81
67
48
88
76
56
35
4yr
87
88
70
41
87
86
62
38
85
83
57
33
92
82
61
40
85
72
50
28
Eastern (Bulgaria. Czechoslovakia. GDR. Hungary. Poland)
0- 14
15-44
45 64
2s 65
173
3 671
2 341
72
83
86
80
74
73
73
63
38
72
64
49
*
70
56
41
*
5yr
85
85
64
33
85
83
55
30
85
80
50
20
92
80
54
32
*
69
44
21
0
52
34
•
1970-1974
n
286
5510
3 672
272
65
1 143
911
40
144
2 473
956
7
134
3215
2 300
145
53
1078
1210
50
34
1262
408
1
% Survival
2yr
80
84
78
63
82
81
79
68
77
77
65
•
75
74
64
54
81
70
54
•
•
45
40
•
4yr
71
74
60
38
80
72
60
*
62
65 '
48
•
65
62
47
32
74
57
38
•
*
29
19
•
6yr
64
68
48
23
75
64
47
*
57
58
38
*
60
55
36
19
70
51
27
*
*
20
10
*
Syr
60
63
39
16
75
60
36
*
51
53
30
•
55
50
28
*
64
47
22
•
*
16
6
*
10 yr
58
59
31
*
75
55
26
*
47
49
23
*
52
46
21
•
62
44
17
*
•
13
•
•
Number of patients at time zero (n) is shown
An asterisk (*) denotes less than 30 patients at risk
survival figures were given in the Combined Report on
Regular Dialysis and Transplantation in Europe, XVI,
1985, which was provided for all the renal units supplying
their patient data to the EDTA Registry.) Survival rates
differed little between the Latin group of countries, where
the proportional contribution of transplantation has been
relatively small, and the Benelux countries and the British
Isles where transplantation rates have been intermediate.
Lower survival was obtained in the Nordic countries with
their traditionally high transplantation rates. Eastern
countries showed low survival rates and the contribution
of transplantation was small.
The proportional contribution of hospital (or centre)
haemodialysis, home haemodialysis, intermittent perito-
neal dialysis, continuous peritoneal dialysis and trans-
plantation to patient survival in the six geographical
regions is shown in Fig. 4 for the two large cohorts aged
15-44 and 45-64 years at commencement of renal replace-
ment therapy in 1980-1984, and in Fig. 5 for patients aged
15-44 years who commenced renal replacement therapy
in 1970-1974. The contribution of transplantation was
larger and that of hospital haemodialysis smaller in
paediatric patients of all regions, whilst the opposite,
a larger contribution of hospital haemodialysis and a
smaller contribution of transplantation, was observed in
the older age groups than are shown in Figs 4 and 5.
Figure 6 summarises interval mortality on all forms of
treatment as well as separately on hospital haemodialysis,
home haemodialysis, continuous peritoneal dialysis and
with a functioninggraft (primary or regraft, and all sources
of donor kidney) for patients commencing treatment in the
six geographical regions in 1980-1984. There were clearly
marked differences between geographical regions in
annual death rates (i .e. the proportion of patients at risk in
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Age g'oup li-ft*
Age group I5-««
100- . j
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Fig. 4. Proportional contribution of different forms of renal replacemenl
iherapy at intervals after the dale of staning renal replacement therapy
in patients commencing treatment I9S0- f9S44. shown according to age
group. Geographical regions are defined in Table 2.
Fig. 5. Proportional contribution ot'different forms of renal replacemenl
therapy at intervals after the dale ofstaning renal replacemenl therapy
in patienis commencing treatment 1970-1974. age group 15-44 years.
Geographical regions are defined in Table 1.
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any one year after start of renal replacement therapy who
died) on specific treatment modalities. These differences
appear to have resulted from differing treatment policies.
The trend in the British Isles to move patients on to home
haemodialysis might have generated a greater number of
high-risk home-dialysis patients and thus perhaps explain
the higher mortality rates in British patients as compared
to residents of Latin countries. The high transplantation
rates in Nordic countries can be assumed to have
decreased rapidly the number of healthy long-term dialy-
sis patients and generated a sizeable number of transplant
failures who were at increased risk of dying whilst back on
dialysis. The Nordic population on any form of dialysis
during the third to fifth year of renal replacement therapy
would thus in no way be comparable to the dialysis
populations in the Federal Republic of Germany, Austria
and the Latin countries.
In the course of the years, the annual death rates in
patients on hospital haemodialysis changed little, and the
variability in death rates on continuous peritoneal dialysis
showed no regular trends. Death rates with a functioning
graft were definitely at their peak during the first year of
this therapy, when all grafted patients go through the
early high-risk post-transplant period. Thereafter, during
the second to fifth year of renal replacement therapy,
death rates with a functioning graft were consistently low
because patients going through the early post-transplant
period after a first graft or regraft were outnumbered by
far by recipients of a graft that had been functioning for a
few months or longer. It should be kept in mind that
complications acquired with a failing graft may ultimately
cause death weeks or months later, which appear as
deaths on dialysis in this type of analysis.
Survival According to Primary Renal Disease
Systemic diseases, including diabetic nephropathy,
primary hypertension and malignancies which cause end-
stage renal failure, increase the risk of dying in comparison
to the common primary renal diseases [4-9]. Separate
survival rates were, therefore, calculated for patients with
so-called standard primary renal diseases (chronic renal
failure of uncertain aetiology, chronic glomerulonephritis,
chronic pyelonephritis/interstitial nephritis, toxic nephro-
pathies, polycystic kidney diseases), for patients with
diabetic nephropathy, and for those with all other diseases
including lupus erythematosus, myeloma, renal vascular
diseases, etc. Mortality was confirmed to be higher in
patients with systemic diseases (Table 3). This was par-
ticularly obvious in young patients with diabetes mellitus
Ag> gr*m> !»-•«
Fig. 6. Per cent mortality in each of the first 5 years of renal replacement
therapy according to method of renal replacement therapy 1980-1985.
shown according to age group. Geographical regions are defined in
Table 2. o
J
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Table 3. Patient survival after first renal replacement therapy (RRT) 1980-1984 with standard primary renal
disease (PRD) (which includes chronic renal failure aetiology uncertain, glomerulonephritis, pyelonephritis/
interstitial nephritis, nephropathy caused by drugs or toxic agents and cystic kidney diseases), with diabetic
nephropathy and with other primary renal diseases
115
Age at
RRT
(years)
0-14
15-44
45-64
£65
Standard PRD
n
1505
24 977
31027
11 141
% Survival
2yr
90
89
82
65
5yr
83
79
60
34
Diabetic nephropathy
n
*
2 678
3 739
1240
% Survival
2yr
*
66
57
42
5yr
*
44
25
13
Other PRD
n
818
5 700
8344
3 526
% Survival
2yr
88
86
72
55
5yr
82
75
49
26
An asterisk (*) denotes less than 30 patients at risk
who succumbed at three times the rate of their counter-
parts with standard primary renal diseases (Fig. 7).
From this analysis of survival according to primary
renal disease emerges an explanation for the lower overall
survival figures obtained in Nordic countries particularly
in the 15-44-year-old cohort. There, only 53% of patients
had standard primary renal diseases against almost 40%
with diabetic nephropathy. As patient survival according
to primary renal disease differed little between Western
European regions both for standard primary renal disease
and for diabetic nephropathy (Table 4), the lower overall
survival results were mainly due to the high proportion
of patients with diabetes mellitus among the uraemic
population in Nordic countries.
Survival on Haemodialysis/Haemofiltration
In the section of the EDTA patient questionnaire which
relates to treatment sequence and which is used for sur-
vival calculations, no distinction has been made between
various methods of extracorporeal blood purification. We
know, however, that a minority of patients have under-
gone haemofiltration, haemodiafiltration, or haemo-
dialysis combined with haemoperfusion [10] and not
infrequently have been changed from one of these
methods to another. The majority have been treated with
haemodialysis, which continues to be the most widely
used mode of renal replacement therapy all over the world
with the exception of the Nordic and British groups of
countries, where the numbers of patients with functioning
grafts exceed those on haemodialysis [10].
The figures presented in Table 5 show survival from the
start of renal replacement therapy with haemodialysis/
haemofiltration. The end point of the calculation was
either the date of death or the date of change to another
treatment mode, i.e. peritoneal dialysis or transplan-
tation. A change from centre to home haemodialysis/
% Annual mortality
Age at
first RRT
15- 34
35- 44
45-54
55-60
> 6 5
301
2 0 -
30-1
2 0 -
40-
30-
20-
10-
Standard Diabetic 5 year survival
standard diabetic
82%
75%
sit
371
66* 271
54% 23%
34% 13%
1
Years after commencing RRT
Fig. 7. Per cent annual mortality of patients with standard primary renal
diseases compared to diabetics, shown according to age at first renal
replacement therapy (RRT). Percent survival at 5 years is given for each
of these groups. Standard primary renal diseases are defined in Table 3.
haemofiltration was disregarded, since home treatment is
not performed in some countries, and only available to a
small group of more or less selected patients in many other
countries. With the majority of patients with end-stage
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Table 4. Patient survival after first renal replacement therapy in 1980-1984 for patients with standard primary renal diseases (PRD) and with diabetic
nephrnpathy. Results are shown according to geographical region
Geographical
region
Latin
Benelux
FRG/Austria
British Isles
Nordic
Eastern
Standard PRD
Age group
15-44
n
8617
1 190
4 225
2640
859
3 443
% Survival
2yr
95
95
92
93
93
74
5yr
89
88
84
84
85
54
45-64
n
11827
1729
7311
2 574
1472
2114
% Survival
2yr
87
85
82
77
74
65
Syr
69
64
60
56
52
36
Diabetic nephropathy
Age group
15-44
n
634
147
567
346
617
138
% Survival
2 yr 5 yr
68 41
75
66 46
70 47
66 48
38
45-64
n
1423
208
1114
296
261
100
% Survival
2yr
63
52
57
57
45
30
5yr
30
*
24
*
*
*
An asterisk (*) denotes less than 30 patients at risk
Standard primary renal diseases are defined in Table 3
Geographical regions are defined in Table 2
Table S. Patient survival on first haemodialysis (including home haemodialysis and haemofiltration) according to age at start of treatment. Results
are given according to year of first renal replacement therapy (RRT)
Age at
RRT
(years)
0-14
15-34
35-44
45-54
55-64
£ 6 5
Year of first
1980-1984
n
1894
16 858
13 252
19 507
18919
13217
renal replacement
% Survival
ly r
95
94
92
91
88
81
2yr
91
89
86
83
77
65
therapy
3yr
89
85
80
76
69
53
4yr
86
82
75
70
60
43
5yr
82
80
71
63
53
35
1970-1974
n
733
9 060
6 843
6907
3 099
549
% Survival
2yr
79
81
77
75
68
59
4yr
73
72
64
59
46
35
6yr
65
66
56
47
32
21
8yr
62
62
49
38
23
12
10 yr
60
58
45
31
15
7
I2yr
59
55
39
25
10
*
15yr
*
51
31
17
*
*
Number of patients at risk at time zero (n) is shown. An asterisk (*) denotes less than 30 patients at risk
renal disease receiving treatment by haemodialysis, it is
not surprising that survival figures for any age group and
at any point in time closely resemble those obtained for all
forms of renal replacement therapy combined, shown in
Table 1.
Figure 8 shows the lower survival rates on haemo-
dialysis for patients with diabetic nephropathy as com-
pared to patients with standard primary renal diseases.
The difference in survival is entirely comparable to that
shown for patients on renal replacement therapy in Fig. 7
or Table 3.
Lower survival rates resulting from higher annual
mortality of 12.7% for 20-44-year-old and 34% in over
65-year-old patients on dialysis were reported from the
United States for patients starting dialysis in 1977 [9].
Apart from the acceptance of more high-risk patients in
the United States, this difference in the calculated survival
'Standard PRD
Tun «n ririt
Fig. 8. Patient survival on first haemodialysis 1980-1984. standard pri-
mary renal diseases (PRD) compared to diabetic nephropathy. Standard
primary renal diseases are defined in Table 3.
rates might be explained by the fact that patients who had
received transplants were excluded from the analysis. This
effectively removed from the analysis a part of the patient
population, particularly in the younger age groups, which
Survival on Renal Replacement Therapy
was surviving at least up to the moment of transplan-
tation. The number of patients surviving on dialysis was
thereby reduced, whilst all the deaths on dialysis were
included. The European survival rates for patients on
haemodialysis should, therefore, not be weighed against
these American figures.
Survival on Continuous Peritoneal Dialysis
(CAPD/CCPD)
Continuous peritoneal dialysis as a distinct entity was
introduced as one of five methods of treatment on
the EDTA Registry patient questionnaire in 1981.
Accordingly, patient survival on continuous peritoneal
dialysis is shown for patients starting treatment in 1981-
1984 (Table 6). The survival rates do not differ appreciably
from those obtained for patients on all forms of renal
replacement therapy shown in Table 1. For several
reasons these figures should not be compared to those of
patients on haemodialysis. Selection of patients for either
haemodialysis or CAPD is unlikely to have occurred in a
randomised fashion. Local preference, availability of
facilities, anticipated complications with vascular access,
or diabetes mellitus may have determined whether a
patient was started on CAPD rather than on haemodialy-
sis. Conditions which might have been associated with
definite differences in mortality were thus likely to show
an uneven distribution between patients on CAPD as
compared to haemodialysis. In fact, a much higher pro-
portion of patients with diabetes mellitus was treated with
CAPD. and the difference in survival on CAPD compared
to that of patients with standard primary renal diseases
(Fig. 9) was almost as striking as shown in Table 3 for any
type of renal replacement therapy. Thus, taking primary
renal disease into account, survival achieved by CAPD
wascertainly no lower, and possibly even better, than with
other modes of treatment.
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Age at start r-IQ|
Table 6. Patient survival on first CAPD,CCPD. Results are shown
according to age at start of renal replacement therapy in 1981-1984
Aeeat
first
RRT
(years)
0-14
15-44
45-64
565
n
452
3082
5 399
2 403
% Survival
lyr
95
94
87
77
2yr
90
88
74
57
3yr
90
82
63
42
4yr
*
74
54
30
Yuri on CAPO
An asterisk (*) denotes less than 30 patients at risk
Fig. 9. Patient survival on first CAPD 1981-1984, standard primary
renal diseases (PRD) compared with diabetic nephropathy. Standard
primary renal diseases are defined in Table 3.
Survival After Renal Transplantation
Patient and Graft Survival After First Cadaveric
Graft
The improvement in patient and graft survival rates
between the early seventies and the eighties is particularly
striking for cadaveric transplantation (Tables 7,8). This is
not only due to the tremendous decline in the risk of dying
during the early postoperative period, but also results
from a lower interval mortality at any time after the first
few post-transplant months a decade later. Figure 10
shows annual mortality after grafting, which was higher
during the first year and then decreased to below 3%
interval mortality in the 15-44-year-old recipients, and to
some 6% in the 45-64-year-old cohort. This mortality
involves all deaths, including also those occurring at any
time after first graft failure. Taking all these deaths into
account, patient survival rates in all age groups have,
nevertheless, risen above those of the dialysis population
as a whole. Several explanations are possible. Some lethal
complications encountered in dialysed patients might no
longer occur with a successful transplant, or transplan-
tation might be performed in a physically fitter dialysis
population that would have better survival despite trans-
plantation. Whatever the explanation, it seems no longer
true that the prospect of a better quality of life with
a functioning transplant has to be balanced against
a markedly increased risk of an early death after
transplantation.
Two different ways of computing and depicting survival
in transplantation are demonstrated in Fig. 11. The upper
curve shows survival with a graft, i.e. only those deaths
occurring whilst the graft was still functioning were con-
sidered, and all patients who survived graft failure were
treated as lost to follow-up at the moment when they
moved to any other mode of renal replacement therapy
(or were regrafted). Interval mortalities were lower using
this method for computing survival, despite the fact that
the number of patients at risk becomes smaller at each
interval. However, increased mortality after graft failure
or during the early post-transplant period of repeated
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Table 7. Patient survival after cadaver first graft, shown according to age at grafting and year of grafting
Report from the EDTA Registry
Age at
grafting
(years)
Year of cadaver first graft
1980-1984 1970-1974
% Survival % Survival
0-4
15-44
45-64
» 6 5
911
12 794
6 161
173
ly r
93
93
86
78
2yr
91
91
81
71
3yr
90
88
77
66
4yr
88
86
71
58
5yr
86
83
67
53
191
4 396
I 837
7
2yr
79
72
55
*
4yr
71
64
45
*
6yr
64
58
37
*
Syr
59
53
30
*
10 yr
57
49
24
*
12 yr
54
45
21
*
15 yr
. .
39
15
*
An asterisk (*) denotes less than 30 patients at risk
Table 8. Survival of cadaver first grafts, shown according to age of recipient and year of grafting
Age at
grafting
(years) 1980-1984
Year of cadaver first graft
1970-1974
% Graft survival % Graft survival
0-14
15-44
45-64
>65
908
12761
6 150
173
ly r
69
69
67
63
2yr
60
63
61
58
3yr
54
58
56
54
4yr
50
54
50
46
5yr
44
51
46
*
189
4 385
1837
7
2yr
56
47
39
*
4yr
48
40
31
*
6yr
41
34
26
*
Syr
35
31
22
•
10 yr
29
27
18
*
12yr
25
24
15
*
15yr
*
20
11
#
An asterisk (*) denotes less than 30 patients at risk
Age at grafting 15-411
Yean after grafting
Fig. 10. Annual mortality after first cadaver graft 1980-1984. according
to age at grafting.
grafting is not considered. The survival curve, therefore,
has a 'better' appearance. The EDTA Registry has usually
shown survival after grafting by considering all deaths
occurring at any time after the event of transplantation
[11]. This is depicted by the lower curve in Fig. 11, and as
shown in this paper in all the Tables on patient survival
after grafting.
The age dependence of survival on renal replacement
therapy in general was also apparent in patient and
graft survival for cadaveric transplantation performed in
1970-1974. A decade later, patient survival continued
to be better in the younger compared to the older graft
recipients, but the difference was less marked. Low mor-
tality, particularly in cadaveric graft recipients older than
65 at grafting might be explained by more careful selection
of low-risk candidates for transplantation in older patient
groups. This may also explain why the impact of age on
the first cadaveric graft survival was almost completely
lost in 1980-1984. In contrast, more high-risk (including
increasingly younger) paediatric patients have received
grafts in more recent years. Graft survival has thus
improved in all paediatric age groups, but the rising pro-
portion of high-risk paediatric recipients aged 0-4 and
5-9 years (Fig. 12) has resulted in almost unchanged
average graft survival rates for the paediatric population
as a whole.
Patients with diabetic nephropathy had lower graft sur-
vival as shown in Fig. 13. The obvious reason for lower
Survival on Renal Replacement Therapy 119
5 10 15
Years after grafting
Fig. II. Per cent patient survival, cadaver first graft 1970-1974 and age at
grafting 15-44 years.
Standard PRD
0 1 1 J « 5
Years after grafting
Fig. 14. Per cent patient survival after first cadaver transplant 1980-1984
according to age at start of treatment, standard primary renal diseases
(PRD) compared to diabetic nephropathy. Standard primary renal dis-
eases are denned in Table 3.
Years after grafting
Fig. 12. Per cent cadaver first graft survival in paediatric patients 1980-
19S4, according to recipient age at grafting.
I graft!
surviving
Age at grafting
- \ Standard PRD
Diabetic N.) •
2 J
Years after grafting
Fig. 13. Per cent first cadaver graft survival 1980-1984 according to
recipient age al grafting, standard primary renal diseases (PRD) com-
pared to diabetic nephropathy. Standard primary renal diseases are
defined in Table 3.
graft survival was the markedly higher rate of death with
a functioning graft which restricted survival at 5 years
to 54% in the 15-44-year-old diabetic nephropathy
recipients (Fig. 14).
Patient and Graff Survival After Living Related
Donor First Transplantation
Tables 9 and 10 show results obtained in patients with
living related donor first grafts. The exact genetic relation-
ship was not recorded in the early seventies but, in 1980—
1984, the percentage of HLA-identical sibling grafts was
29%, of haploidentical sibling grafts 11 %, and of parental
grafts 58% (Table 11). Non-identical sibling grafts were
used rarely (1 %) and genetic relationship of sibling graft
donor to recipient was recorded as unknown in 1% of
cases. The great majority of paediatric recipients received
parental grafts, whereas almost half of the recipients aged
over 45 at grafting received identical sibling grafts. Both
patient and graft survival rates were superior to those
obtained in cadaveric transplantation and improved
during the last decade. Graft survival of haploidentical
sibling and parental grafts were similar and, as was to be
expected, was inferior to the graft survival of identical
sibling grafts (Fig. 15).
Regraft Survival
Selection of patients by age at regrafting can be problem-
atical with the current analytical software available for
the EDTA computer. For this reason, and in order to
obtain a sample of patients comparable to recipients of
first grafts, age groups for second cadaveric transplan-
tation were formed by using the year of birth. Similarly to
first transplantation, results of graft and patient survival
after second cadaveric transplantation have markedly
improved within the last decade. The living donor second
graft survival rate was much better than that obtained for
cadaveric second grafts and did not differ from the living
donor first graft survival rate (Tables 12 and 13).
Second cadaveric graft survival for patients aged 15-44
years at regrafting was also computed according to the
fate of the first graft. One group was selected because the
first graft had been lost within 6 months due to rejection,
the other group because of a first-graft survival of over
one year. The difference in second cadaveric graft survival
between these two groups is striking. In those patients
whose first graft had been functioning for more than one
year, second graft survival was superior even to average
first graft survival (Fig. 16). As many as 9% of second
grafts in patients who had rejected the first graft within 6
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Table 9. Patient survival after live related donor first graft, shown according to age of recipient and year of grafting
Age at
grafting
(years)
0-14
15-44
>45
Year of live related donor first graft
1980-1984
n
268
1913
229
% Survival
l y r
95
95
88
2yr
95
93
83
3yr
94
91
78
4yr
92
89
72
Syr
92
87
72
1970-1974
n
11
766
88
% Survival
2yr
92
85
81
4yr
82
78
64
6yr
75
72
62
Syr
71
68
53
10 yr
69
65
47
12 yr
69
62
45
15 yr
•
56
•
An asterisk (*) denotes less than 30 patients at risk
Table 10. Survival of live related donor first grafts according to age of recipient and year of grafting
Age at
grafting
(years)
Year of live related donor first graft
1980-1984 1970 1974
% Graft survival % Graft survival
0-14
15-44
5*45
268
1912
229
l y r
83
82
77
2yr
78
77
72
3yr
71
74
67
4yr
63
70
62
5yr
61
66
60
77
766
85
2yr
74
70
66
4yr
58
63
56
6yr
44
56
55
8yr
39
52
46
10 yr
*
49
39
12 yr
•
43
*
15 yr
*
37
*
An asterisk (*) denotes less than 30 patients at risk
Table I I . Source of living related donor first graft 1980-1984
Age at
grafting
(years)
0-14
15-44
£ 4 5
All
Percent
Parent
94
58
20
58
Sibling
ident
5
29
53
29
haplo
1
10
25
11
non/?
0
3
2
2
Ident = HLA identical sibling graft; haplo = haploidentical sibling graft:
non/? = non-identical sibling graft, or genetic relationship of sibling
graft donor to recipient recorded as unknown
Fig. 15. Per cent live related donor first graft survival 1980-1984 for
sibling and parental grafts, recipient age at grafting 15-44 years.
months never functioned, and another 27% failed within
3 months. Thereafter, no difference could be detected in
the interval graft failure rates of the two groups, which
was also similar to the interval failure rate of first grafts.
Rapid rejectors of a first graft thus appear to lose second
or subsequent grafts at a much higher rate. This same
reason may explain the restricted survival of third cada-
veric grafts, which nevertheless has improved in recent
years (Table 14). A sizeable proportion of third cadaveric
grafts never functioned, i.e. 10% of third grafts as com-
pared to 6% on average of second grafts and 3% of first
grafts performed in 1980-1984. Only 58% of third grafts
functioned up to three months, although interval graft
failure rates thereafter did not appear to differ from those
of first or second cadaveric grafts.
Conclusions
Despite differing treatment strategies, survival rates all
over Europe were found to be similar. Transplantation
has been used preferentially and for all age groups in
Nordic countries, hospital or centre dialysis was the salient
mode of treatment in Latin countries, and both home
haemodialysis and CAPD were prominently applied in
the British Isles. Survival rates improved between the
seventies and the early eighties, and this was particularly
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Table 12. Patient survival after second graft according to year of grafting. Results are shown separately for patients with cadaver grafts according to
age at grafting and with living related donor grafts
Source
_r
second
graft
Cadaver
Living
donor
Age at
(years)
0-19
15-44
£45
All
Year of second grafting
1980-1984
n (Year of
birth)
205 (£1965)
1 504 (1940-64)
458 (<1935)
139 (any)
% Survival
lyr
95
94
84
96
2yr
94
91
76
90
3yr
92
89
70
88
4yr
88
87
65
88
5yr
*
85
61
*
1970-1974
n
37
518
152
25
(Year of
birth)
(£1955)
(1930-54)
(<1925)
(any)
% Survival
lyr
81
77
63
2yr
78
71
49
3yr
*
66
43
5yr
57
30
8yr 10 yr
* *
49 45
20 •
An asterisk (•) denotes less than 30 patients at risk
Table 13. Survival of second grafts according to year of grafting. Results are shown separately for cadaver grafts according to age at grafting and for
living related donor grafts
Source
of
second
graft
Cadaver
Living
donor
Age at
grafting
(years)
0-19
15-44
£45
All
Year of second grafting
1980-1984
n (Year of
birth)
205 (£1965)
1495 (1940-64)
457 (< 1935)
139 (any)
% Graft Survival
lyr
68
65
54
82
2yr
62
59
46
76
3yr
51
54
41
75
4 yr 5 yr
• *
50 47
37 •
75 *
1970-1974
n
37
516
152
25
(Year of
birth)
(£1955)
(1930-54)
(<1925)
(any)
% Graft Survival
lyr
43
49
45
2yr
41
35
3yr
38
28
Syr
31
22
8yr 10 yr
24 20
14 *
An asterisk (•) denotes less than 30 patients at risk
t intervil
failure
1 2 3 « 5
Yeari after second grafting
Fig. 16. Per cent second cadaver graft survival and interval failure 1980-
1984. recipient age group 15-44 years and year of birth 1940-1964.
striking in transplantation. Some differences in patient
survival between geographical regions might be attributed
to differing treatment policies. The early post-transplant
period still carries an increased risk of dying, although this
has been reduced with grafts performed in recent years.
The high rate of transplantation early in the course of
renal replacement therapy in Nordic countries is, there-
fore, associated with slightly lower survival of the uraemic
population during the early phase of treatment. However,
the most important explanation for the higher overall
mortality in Nordic as compared to Latin countries is
given by the large proportion of Nordic patients with
diabetic nephropathy who, particularly in the younger
age groups, succumbed at a markedly higher rate than
their non-diabetic counterparts.
Because of differing treatment policies or differing
reasons for preferentially selecting one or another method
of renal replacement therapy, one should not compare
survival or mortality on different treatment modalities.
All methods have their virtues and their disadvantages
and may contribute equally to the survival of the uraemic
population as demonstrated in the various tables shown
in this paper.
Patients on renal replacement therapy are still far from
approaching the survival rates of the general population
which has a mortality of less than 1 % annually below the
age of 65 in females and 55 in males. Nevertheless, survival
rates have improved in the course of the last decade and
can be expected to exceed 65% for young adults and 25%
for patients aged 55-64 years at 10 years after starting
renal replacement therapy in the early eighties.
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Table 14. Survival of cadaver third grafts according to year of grafting
Year of grafting
1980-1984 1970-1974
% Graft survival % Graft survival
lyr
285 52
2yr
47
3yr
39
4yr
35
5yr
* 71
lyr
41
2yr
*
An asterisk (*) denotes less than 30 patients at risk
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